This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus
Clinical trial NCT00531063 · COMPLETED
Trial details
- NCT number
- NCT00531063
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2005-08-01
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.